AlphaFold predicted structure
MMAB · Q96EY8

Mean pLDDT
81.8/ 100
Confident
250 residues
Confidence breakdown
- Very high(≥ 90)66%
- Confident(70–90)9%
- Low(50–70)5%
- Very low(< 50)19%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
metabolism of cobalamin associated B
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalHyperammonaemia
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
Fetal anomalies
BIALLELIC, autosomal or pseudoautosomalmethylmalonic aciduria, cblB type
Vitamin B12-responsive methylmalonic acidemia type cblB
methylmalonic aciduria cblb type
vitamin B12-responsive methylmalonic acidemia
methylmalonic acidemia
hereditary disease
neurodegenerative disease
Methylmalonic aciduria
hearing loss disorder
gout
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Corrinoid adenosyltransferase MMAB
Converts cob(I)alamin to adenosylcobalamin (adenosylcob(III)alamin), a coenzyme for methylmalonyl-CoA mutase, therefore participates in the final step of the vitamin B12 conversion (PubMed:12514191). Generates adenosylcobalamin (AdoCbl) and directly delivers the cofactor to MUT in a transfer that is stimulated by ATP-binding to MMAB and gated by MMAA (Probable)
MMAB · Q96EY8

Mean pLDDT
81.8/ 100
Confident
250 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0